These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9769621)

  • 41. Comparison of intravenous patient-controlled analgesia with tramadol versus morphine after microvascular breast reconstruction.
    Silvasti M; Svartling N; Pitkänen M; Rosenberg PH
    Eur J Anaesthesiol; 2000 Jul; 17(7):448-55. PubMed ID: 10964147
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intravenous ketamine infusion as an adjuvant to morphine in a 2-year-old with severe cancer pain from metastatic neuroblastoma.
    Tsui BC; Davies D; Desai S; Malherbe S
    J Pediatr Hematol Oncol; 2004 Oct; 26(10):678-80. PubMed ID: 15454842
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fentanyl buccal tablets for breakthrough pain in highly tolerant cancer patients: preliminary data on the proportionality between breakthrough pain dose and background dose.
    Mercadante S; Ferrera P; Adile C; Casuccio A
    J Pain Symptom Manage; 2011 Sep; 42(3):464-9. PubMed ID: 21477977
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Sustained-release Opioids: Morphine, Oxycodone and Tapentadol].
    Takahashi Y; Iseki M
    Masui; 2015 Nov; 64(11):1133-40. PubMed ID: 26689063
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Oral transmucosal fentanyl: new preparation. For breakthrough cancer pain when morphine fails.
    Prescrire Int; 2002 Aug; 11(60):106-7. PubMed ID: 12199262
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A review of rapid-onset opioids for breakthrough pain in patients with cancer.
    Simon SM; Schwartzberg LS
    J Opioid Manag; 2014; 10(3):207-15. PubMed ID: 24944071
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Responsible, Safe, and Effective Prescription of Opioids for Chronic Non-Cancer Pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines.
    Manchikanti L; Kaye AM; Knezevic NN; McAnally H; Slavin K; Trescot AM; Blank S; Pampati V; Abdi S; Grider JS; Kaye AD; Manchikanti KN; Cordner H; Gharibo CG; Harned ME; Albers SL; Atluri S; Aydin SM; Bakshi S; Barkin RL; Benyamin RM; Boswell MV; Buenaventura RM; Calodney AK; Cedeno DL; Datta S; Deer TR; Fellows B; Galan V; Grami V; Hansen H; Helm Ii S; Justiz R; Koyyalagunta D; Malla Y; Navani A; Nouri KH; Pasupuleti R; Sehgal N; Silverman SM; Simopoulos TT; Singh V; Solanki DR; Staats PS; Vallejo R; Wargo BW; Watanabe A; Hirsch JA
    Pain Physician; 2017 Feb; 20(2S):S3-S92. PubMed ID: 28226332
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effervescent morphine results in faster relief of breakthrough pain in patients compared to immediate release morphine sulfate tablet.
    Freye E; Levy JV; Braun D
    Pain Pract; 2007 Dec; 7(4):324-31. PubMed ID: 17986159
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fentanyl buccal tablet.
    Messina J; Darwish M; Fine PG
    Drugs Today (Barc); 2008 Jan; 44(1):41-54. PubMed ID: 18301803
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparative efficacy of patient-controlled administration of morphine, hydromorphone, or sufentanil for the treatment of oral mucositis pain following bone marrow transplantation.
    Coda BA; O'Sullivan B; Donaldson G; Bohl S; Chapman CR; Shen DD
    Pain; 1997 Sep; 72(3):333-46. PubMed ID: 9313274
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The use of ketamine as rescue analgesia in the recovery room following morphine administration--a double-blind randomised controlled trial in postoperative patients.
    Gillies A; Lindholm D; Angliss M; Orr A
    Anaesth Intensive Care; 2007 Apr; 35(2):199-203. PubMed ID: 17444308
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Forty-eight hours of postoperative pain relief after total hip arthroplasty with a novel, extended-release epidural morphine formulation.
    Viscusi ER; Martin G; Hartrick CT; Singla N; Manvelian G;
    Anesthesiology; 2005 May; 102(5):1014-22. PubMed ID: 15851890
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy and safety of fentanyl sublingual spray for the treatment of breakthrough cancer pain: a randomized, double-blind, placebo-controlled study.
    Rauck R; Reynolds L; Geach J; Bull J; Stearns L; Scherlis M; Parikh N; Dillaha L
    Curr Med Res Opin; 2012 May; 28(5):859-70. PubMed ID: 22480131
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long-term safety of fentanyl sublingual spray in opioid-tolerant patients with breakthrough cancer pain.
    Minkowitz H; Bull J; Brownlow RC; Parikh N; Rauck R
    Support Care Cancer; 2016 Jun; 24(6):2669-75. PubMed ID: 26780504
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Postoperative analgesia and vomiting, with special reference to day-case surgery: a systematic review.
    McQuay HJ; Moore RA
    Health Technol Assess; 1998; 2(12):1-236. PubMed ID: 10103349
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sustained-release morphine sulfate with sequestered naltrexone for moderate to severe pain: a new opioid analgesic formulation and beyond.
    Ruan X
    Expert Opin Pharmacother; 2011 May; 12(7):999-1001. PubMed ID: 21470064
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dynamics of breakthrough pain vs. pharmacokinetics of oral morphine: implications for management.
    Zeppetella G
    Eur J Cancer Care (Engl); 2009 Jul; 18(4):331-7. PubMed ID: 19473378
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Use of opioids in the treatment of severe pain in terminally ill patients--dying should not be painful.
    Moynihan TJ
    Mayo Clin Proc; 2003 Nov; 78(11):1397-401. PubMed ID: 14601699
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Use of buccal morphine in the management of pain in children with life-limiting conditions: Results of a laboratory study.
    McCulloch R; Sattar M; Henderson EM; Lane ME; Bluebond-Langner M
    Palliat Med; 2018 Feb; 32(2):554-558. PubMed ID: 28631529
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A comparison of oral controlled-release morphine and oxycodone with transdermal formulations of buprenorphine and fentanyl in the treatment of severe pain in cancer patients.
    Nosek K; Leppert W; Nosek H; Wordliczek J; Onichimowski D
    Drug Des Devel Ther; 2017; 11():2409-2419. PubMed ID: 28860712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.